Latest News about XBI
Recent news which mentions XBI
Top trades for 2024 encircle Big Tech, but not so much the stocks, Bank of America says
December 01, 2023
From MarketWatch
S&P 500, Nasdaq Slip As Tech Underperforms, Oil Reacts to OPEC+: What's Driving Markets Thursday?
November 30, 2023
From Benzinga
Stocks Drift Higher On Stronger GDP Data, Oil Rebounds As OPEC+ Mulls Cuts: What's Driving Markets Wednesday?
November 29, 2023
From Benzinga
US Stocks Rebound As Treasury Yields, Dollar Fall On Dovish Fed Remarks, Gold Hits $2,040: What's Driving Markets Tuesday?
November 28, 2023
From Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
November 16, 2023
From InvestorPlace
From Motley Fool
Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel votes against it
October 06, 2023
From MarketWatch
This fund shows that industry expertise can help you make a lot of money in the stock market
October 02, 2023
From MarketWatch
Don’t Miss the Boom: 3 ETFs Set to Explode Higher
September 27, 2023
From InvestorPlace
VBI Vaccines’ pan-coronavirus vaccine candidate produced broad protection against variants of concern
September 27, 2023
From MarketWatch
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
September 13, 2023
From InvestorPlace
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
September 08, 2023
From Benzinga
If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now
August 25, 2023
From Benzinga
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
August 22, 2023
From InvestorPlace
5 Meme Stocks to Sell Immediately, According to AI
August 22, 2023
From InvestorPlace
Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart attacks and strokes
August 09, 2023
From MarketWatch
Biogen agrees to acquire Reata Pharmaceuticals for $7.3 billion to boost its rare-disease offering
July 28, 2023
From MarketWatch
From MarketWatch
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
From Motley Fool
Bull vs. Bear: How Healthy Are Biotech ETFs?
May 10, 2023
From ETF Trends
ETF flows point to ‘skittish’ investors as it’s ‘a little unwieldy out there’ after Fed rate hikes
May 04, 2023
From MarketWatch
A volatile summer is coming as Fed pause, debt tussle meet. Shelter in these stocks, says strategist
May 01, 2023
From MarketWatch
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
From Benzinga
Biotech ETFs’ Performance Deserves A Look
April 19, 2023
From ETF Trends
Thermo Fisher, Principal Financial Group, And Two Promising ETFs Steal The Show On CNBC's 'Final Trades'
April 14, 2023
From Benzinga
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
April 13, 2023
From Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
April 13, 2023
From Benzinga
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
April 12, 2023
From Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
April 11, 2023
From Benzinga
Time to Spring-Clean...Your Stock Portfolio
April 10, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.